24/06/2024
āϏāĻŽāĻāĻžāϰ⧠āĻāώāϧ āĻŦāĻž āĻā§āύā§āϰāĻŋāĻ āĻāώāϧ āĻšāϞ āĻ āĻāώāϧāĻŋāĻ āĻĒāĻŖā§āϝāĻā§āϞāĻŋ āϝāĻž āϤāĻžāĻĻā§āϰ āĻŦā§āϰā§āϝāĻžāύā§āĻĄā§āĻĄ āϏāĻāĻā§āϰāĻžāύā§āϤ āϏāĻŽāĻāĻžāĻŽā§ āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āϏāĻā§āϰāĻŋāϝāĻŧ āĻāĻĒāĻžāĻĻāĻžāύāĻā§āϞāĻŋ āϏāĻŽā§āĻŽāĻŋāϞāĻŋāϤ āĻāϰā§āĨ¤ āĻāĻ āĻāώāϧāĻā§āϞāĻŋ āϰā§āĻā§āϞā§āĻāϰāĻŋ āĻāϰā§āϤā§āĻĒāĻā§āώāĻā§āϞāĻŋāϰ āĻĒā§āϰāϤāĻŋ āϝāϤā§āύāĻļā§āϞ āĻĒāϰā§āĻā§āώāĻžāĻā§āϞāĻŋ āĻĒāĻžāϰ āĻāϰā§, āϝāĻžāϤ⧠āĻāĻā§āϞāĻŋāϰ āĻā§āĻŖāĻāϤ āĻŽāĻžāύ, āύāĻŋāϰāĻžāĻĒāϤā§āϤāĻž, āĻāĻŦāĻ āĻāĻžāϰā§āϝāĻā§āώāĻŽāϤāĻž āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āĻšāϝāĻŧāĨ¤ āĻāĻā§āϞāĻŋ āĻŦā§āϰā§āϝāĻžāύā§āĻĄā§āĻĄ āĻāώā§āϧāĻā§āϞāĻŋāϰ āϏāĻŽāĻžāύ āĻĨā§āϰāĻžāĻĒāĻŋāĻ āĻĒā§āϰāĻāĻžāĻŦ āϏāĻāϰāĻā§āώāĻŖ āĻāϰā§, āĻāĻŋāύā§āϤ⧠āĻāĻāĻ āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻŽā§āϞā§āϝāϝā§āĻā§āϝ āĻŦāĻŋāĻāϞā§āĻĒ āĻšāĻŋāϏā§āĻŦā§ āĻĻā§āĻāϝāĻŧāĻž āĻšāϝāĻŧāĨ¤
Equivalent medicines, also known as generic medicines, are pharmaceutical products that contain the same active ingredients in the same strength as their branded counterparts. These medicines undergo rigorous testing to ensure they meet stringent quality, safety, and efficacy standards set by regulatory authorities. They offer a cost-effective alternative to brand-name drugs while maintaining identical therapeutic effects, making healthcare more accessible and affordable for patients worldwide.
Jayjit Chakraborty Prasenjit Chakraborty